Back
76
Day Range
$63.54
$67.31
52-Week Range
$38.51
$85.25
Volume
808,345
50D / 200D Avg
$69.58
/
$62.35
Prev Close
$64.51
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -41.1 | 0.4 |
| P/B | 8.0 | 2.9 |
| ROE % | -23.4 | 3.8 |
| Net Margin % | -14.7 | 3.9 |
| Rev Growth 5Y % | 67.7 | 10.0 |
| D/E | 0.3 | 0.2 |
Key Takeaways
Revenue grew 67.73% annually over 5 years — strong growth
Debt/Equity of 0.27 — conservative balance sheet
Negative free cash flow of -22.31M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 78.98%
Capital efficient — spends only 2.18% of revenue on capex
Growth
Revenue Growth (5Y)
67.73%
Revenue (1Y)146.71%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-23.39%
ROIC-12.18%
Net Margin-14.72%
Op. Margin-15.72%
Safety
Debt / Equity
0.27
Current Ratio3.85
Interest Coverage-7.94
Valuation
P/E Ratio
-41.09
P/B Ratio7.95
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 146.71% | Revenue Growth (3Y) | 408.63% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 67.73% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 451.36M | Net Income (TTM) | -66.42M |
| ROE | -23.39% | ROA | -11.81% |
| Gross Margin | 93.20% | Operating Margin | -15.72% |
| Net Margin | -14.72% | Free Cash Flow (TTM) | -22.31M |
| ROIC | -12.18% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.27 | Current Ratio | 3.85 |
| Interest Coverage | -7.94 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -41.09 | P/B Ratio | 7.95 |
| P/S Ratio | 6.05 | PEG Ratio | 1.07 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.73B | Enterprise Value | 2.64B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 451.36M | 182.95M | 17.45M | 25.82M | 57.03M |
| Net Income | -66.42M | -115.55M | -135.89M | -62.09M | -13.83M |
| EPS (Diluted) | -1.59 | -3.07 | -4.62 | -2.52 | -0.67 |
| Gross Profit | 420.68M | 170.13M | 15.85M | 24.86M | 54.95M |
| Operating Income | -70.97M | -120.57M | -143.16M | -62.71M | -12.16M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 562.16M | 376.99M | 265.49M | 227.86M | 178.91M |
| Total Liabilities | 218.73M | 152.46M | 68.50M | 34.96M | 12.18M |
| Shareholders' Equity | 343.43M | 224.53M | 196.99M | 192.90M | 166.73M |
| Total Debt | 93.64M | 72.45M | 30.22M | 20.21M | 1.89M |
| Cash & Equivalents | 183.64M | 94.82M | 224.95M | 71.66M | 171.33M |
| Current Assets | 522.78M | 356.71M | 256.13M | 225.38M | 175.95M |
| Current Liabilities | 135.70M | 80.61M | 36.94M | 15.43M | 11.48M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#7 of 146
Recent Activity
Entered
Full Throttle
Mar 24, 2026